DALLAS, TX
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)THE OSTEOSARCOMA INSTITUTE, founded in 2017, is a community nonprofit in the Medical Research sector that reported $4.2M in total revenue in fiscal year 2024. Revenue surged 204% from the prior year, signaling strong growth momentum. The organization ran a surplus of $1.5M, a strong 35% operating margin.
THE MISSION OF THE OSTEOSARCOMA INSTITUTE IS TO DRAMATICALLY INCREASE TREATMENT OPTIONS AND SURVIVAL RATES IN OSTEOSARCOMA PATIENTS THROUGH IDENTIFYING AND FUNDING THE MOST PROMISING AND BREAKTHROUGH OSTEOSARCOMA CLINICAL TRIALS AND SCIENCE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $4,166,894 | $1,369,434 | +2.0% |
| Expenses | $2,699,475 | $2,748,118 | 0.0% |
| Net Income | $1,467,419 | $-1,378,684 | -2.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| MCHENRY TICHENOR JR | CHAIR OF BOARD OF TRUSTEES | 40.00 |
Officer
Director
|
$0 | $0 | $0 |
| MARY KATHERINE CLARKE | BOARD OF TRUSTEES | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| LISA TICHENOR | BOARD OF TRUSTEES | 2.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL EGGE | BOARD OF TRUSTEES | 2.00 |
Director
|
$0 | $0 | $0 |
| ALLI MURDOFF | BOARD OF TRUSTEES | 2.00 |
Director
|
$0 | $0 | $0 |
| LEE HELMAN | INSTITUTE DIRECTOR | 16.00 |
Key Emp
|
$231,253 | $0 | $231,253 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $4,166,894 | $2,699,475 | $6,267,513 | $1,467,419 |
| 2023 | $1,369,434 | $2,748,118 | $4,763,582 | $-1,378,684 |
| 2022 | $749,958 | $1,383,306 | $6,110,939 | $-633,348 |
| 2021 | $292,501 | $1,824,312 | $6,745,771 | $-1,531,811 |
| 2020 | $453,721 | $1,143,282 | $8,269,582 | $-689,561 |
| 2020 | $453,721 | $1,143,282 | $8,269,582 | $-689,561 |
| 2019 | $375,876 | $340,923 | $9,041,643 | $34,953 |
| 2018 | $9,307,547 | $390,857 | $8,997,823 | $8,916,690 |
Compare THE OSTEOSARCOMA INSTITUTE with other nonprofits in Texas and across the country.